胃食道逆流症（GERD）の世界市場 2024-2028

Technavio社は、胃食道逆流症（GERD）市場をモニターしており、2023年から2028年にかけて8億7,980万米ドル、予測期間中のCAGRは3.2%で成長すると予測しています。

当レポートでは、胃食道逆流症（GERD）市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。高齢者人口の増加、生活パターンの悪化、医薬品や栄養補助食品の過剰使用などが市場を牽引しています。

本調査では、今後数年間の胃食道逆流症（GERD）市場成長を牽引する主要因の1つとして、肥満の蔓延増加を挙げています。また、eコマース市場の拡大やGERDの認知度向上も市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界胃食道逆流症（GERD）市場 2018-2022
• 投与経路別セグメント分析 2018-2022
• タイプ別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：投与経路別

• 市場セグメンテーション
• 比較：投与経路別
• 経口：市場規模と予測 2023-2028
• 非経口：市場規模と予測 2023-2028
• 市場機会：投与経路別

第7章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• 制酸剤：市場規模と予測 2023-2028
• プロトンポンプ阻害薬：市場規模と予測 2023-2028
• H2受容体拮抗薬：市場規模と予測 2023-2028
• 消化管運動促進薬：市場規模と予測 2023-2028
• 市場機会：タイプ別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Abbott Laboratories
• Alkem Laboratories Ltd.
• Apotex Inc.
• AstraZeneca Plc
• Aurobindo Pharma Ltd.
• Bayer AG
• Cipla Inc.
• Dr Reddys Laboratories Ltd.
• Eisai Co. Ltd.
• Fresenius SE and Co. KGaA
• GlaxoSmithKline Plc
• inovapharma.com
• Johnson and Johnson Services Inc.
• Lupin Ltd.
• Perrigo Co. Plc

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Company Market Positioning
• Exhibits10: Parent Market
• Exhibits11: Data Table on - Parent Market
• Exhibits12: Market characteristics analysis
• Exhibits13: Value Chain Analysis
• Exhibits14: Offerings of companies included in the market definition
• Exhibits15: Market segments
• Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits20: Historic Market Size - Data Table on Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits25: Five forces analysis - Comparison between 2023 and 2028
• Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits31: Chart on Market condition - Five forces 2023 and 2028
• Exhibits32: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibits33: Data Table on Route of Administration - Market share 2023-2028 (%)
• Exhibits34: Chart on Comparison by Route of Administration
• Exhibits35: Data Table on Comparison by Route of Administration
• Exhibits36: Chart on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibits38: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits39: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits40: Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
• Exhibits42: Chart on Parenteral - Year-over-year growth 2023-2028 (%)
• Exhibits43: Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
• Exhibits44: Market opportunity by Route of Administration ($ million)
• Exhibits45: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits46: Chart on Type - Market share 2023-2028 (%)
• Exhibits47: Data Table on Type - Market share 2023-2028 (%)
• Exhibits48: Chart on Comparison by Type
• Exhibits49: Data Table on Comparison by Type
• Exhibits50: Chart on Antacid - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Data Table on Antacid - Market size and forecast 2023-2028 ($ million)
• Exhibits52: Chart on Antacid - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Antacid - Year-over-year growth 2023-2028 (%)
• Exhibits54: Chart on PPI - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Data Table on PPI - Market size and forecast 2023-2028 ($ million)
• Exhibits56: Chart on PPI - Year-over-year growth 2023-2028 (%)
• Exhibits57: Data Table on PPI - Year-over-year growth 2023-2028 (%)
• Exhibits58: Chart on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Data Table on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits60: Chart on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
• Exhibits61: Data Table on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
• Exhibits62: Chart on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Data Table on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
• Exhibits64: Chart on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
• Exhibits65: Data Table on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
• Exhibits66: Market opportunity by Type ($ million)
• Exhibits67: Data Table on Market opportunity by Type ($ million)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape2023-2028 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape2023-2028 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits109: Market opportunity By Geographical Landscape($ million)
• Exhibits110: Data Tables on Market opportunity By Geographical Landscape($ million)
• Exhibits111: Impact of drivers and challenges in 2023 and 2028
• Exhibits112: Overview on criticality of inputs and factors of differentiation
• Exhibits113: Overview on factors of disruption
• Exhibits114: Impact of key risks on business
• Exhibits115: Companies covered
• Exhibits116: Matrix on companies position and classification
• Exhibits117: Abbott Laboratories - Overview
• Exhibits118: Abbott Laboratories - Business segments
• Exhibits119: Abbott Laboratories - Key news
• Exhibits120: Abbott Laboratories - Key offerings
• Exhibits121: Abbott Laboratories - Segment focus
• Exhibits122: Alkem Laboratories Ltd. - Overview
• Exhibits123: Alkem Laboratories Ltd. - Business segments
• Exhibits124: Alkem Laboratories Ltd. - Key offerings
• Exhibits125: Alkem Laboratories Ltd. - Segment focus
• Exhibits126: Apotex Inc. - Overview
• Exhibits127: Apotex Inc. - Product / Service
• Exhibits128: Apotex Inc. - Key news
• Exhibits129: Apotex Inc. - Key offerings
• Exhibits130: AstraZeneca Plc - Overview
• Exhibits131: AstraZeneca Plc - Product / Service
• Exhibits132: AstraZeneca Plc - Key news
• Exhibits133: AstraZeneca Plc - Key offerings
• Exhibits134: Aurobindo Pharma Ltd. - Overview
• Exhibits135: Aurobindo Pharma Ltd. - Product / Service
• Exhibits136: Aurobindo Pharma Ltd. - Key offerings
• Exhibits137: Bayer AG - Overview
• Exhibits138: Bayer AG - Business segments
• Exhibits139: Bayer AG - Key news
• Exhibits140: Bayer AG - Key offerings
• Exhibits141: Bayer AG - Segment focus
• Exhibits142: Cipla Inc. - Overview
• Exhibits143: Cipla Inc. - Business segments
• Exhibits144: Cipla Inc. - Key news
• Exhibits145: Cipla Inc. - Key offerings
• Exhibits146: Cipla Inc. - Segment focus
• Exhibits147: Dr Reddys Laboratories Ltd. - Overview
• Exhibits148: Dr Reddys Laboratories Ltd. - Business segments
• Exhibits149: Dr Reddys Laboratories Ltd. - Key news
• Exhibits150: Dr Reddys Laboratories Ltd. - Key offerings
• Exhibits151: Dr Reddys Laboratories Ltd. - Segment focus
• Exhibits152: Eisai Co. Ltd. - Overview
• Exhibits153: Eisai Co. Ltd. - Business segments
• Exhibits154: Eisai Co. Ltd. - Key offerings
• Exhibits155: Eisai Co. Ltd. - Segment focus
• Exhibits156: Fresenius SE and Co. KGaA - Overview
• Exhibits157: Fresenius SE and Co. KGaA - Business segments
• Exhibits158: Fresenius SE and Co. KGaA - Key news
• Exhibits159: Fresenius SE and Co. KGaA - Key offerings
• Exhibits160: Fresenius SE and Co. KGaA - Segment focus
• Exhibits161: GlaxoSmithKline Plc - Overview
• Exhibits162: GlaxoSmithKline Plc - Business segments
• Exhibits163: GlaxoSmithKline Plc - Key news
• Exhibits164: GlaxoSmithKline Plc - Key offerings
• Exhibits165: GlaxoSmithKline Plc - Segment focus
• Exhibits166: inovapharma.com - Overview
• Exhibits167: inovapharma.com - Product / Service
• Exhibits168: inovapharma.com - Key offerings
• Exhibits169: Johnson and Johnson Services Inc. - Overview
• Exhibits170: Johnson and Johnson Services Inc. - Business segments
• Exhibits171: Johnson and Johnson Services Inc. - Key news
• Exhibits172: Johnson and Johnson Services Inc. - Key offerings
• Exhibits173: Johnson and Johnson Services Inc. - Segment focus
• Exhibits174: Lupin Ltd. - Overview
• Exhibits175: Lupin Ltd. - Product / Service
• Exhibits176: Lupin Ltd. - Key news
• Exhibits177: Lupin Ltd. - Key offerings
• Exhibits178: Perrigo Co. Plc - Overview
• Exhibits179: Perrigo Co. Plc - Business segments
• Exhibits180: Perrigo Co. Plc - Key offerings
• Exhibits181: Perrigo Co. Plc - Segment focus
• Exhibits182: Inclusions checklist
• Exhibits183: Exclusions checklist
• Exhibits184: Currency conversion rates for US$
• Exhibits185: Research methodology
• Exhibits186: Information sources
• Exhibits187: Data validation
• Exhibits188: Validation techniques employed for market sizing
• Exhibits189: Data synthesis
• Exhibits190: 360 degree market analysis
• Exhibits191: List of abbreviations

Technavio has been monitoring the gastroesophageal reflux disease (GERD) market and is forecast to grow by USD 879.8 mn during 2023-2028, accelerating at a CAGR of 3.2% during the forecast period. Our report on the gastroesophageal reflux disease (GERD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population, poor lifestyle patterns, and overuse of medicines and dietary supplements.

Technavio's gastroesophageal reflux disease (GERD) market is segmented as below:

By Route Of Administration

• Oral
• Parenteral

By Type

• Antacid
• PPI
• H2 receptor antagonist drugs
• Pro-Kinetic drugs

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising prevalence of obesity as one of the prime reasons driving the gastroesophageal reflux disease (GERD) market growth during the next few years. Also, growing e-commerce market and increasing awareness of GERD will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the gastroesophageal reflux disease (GERD) market covers the following areas:

• Gastroesophageal reflux disease (GERD) market sizing
• Gastroesophageal reflux disease (GERD) market forecast
• Gastroesophageal reflux disease (GERD) market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading gastroesophageal reflux disease (GERD) market vendors that include Abbott Laboratories, Alkem Laboratories Ltd., Apotex Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, inovapharma.com, Johnson and Johnson Services Inc., Lupin Ltd., Perrigo Co. Plc, Pfizer Inc., SRS Life Sciences Pte. Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and The Procter and Gamble Co.. Also, the gastroesophageal reflux disease (GERD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Route of Administration
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022
  • Historic Market Size - Data Table on Global Gastroesophageal Reflux Disease (GERD) Market 2018 - 2022 ($ million)
• 4.2 Route of Administration segment analysis 2018 - 2022
  • Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• 4.3 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.4 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

• 6.1 Market segments
  • Chart on Route of Administration - Market share 2023-2028 (%)
  • Data Table on Route of Administration - Market share 2023-2028 (%)
• 6.2 Comparison by Route of Administration
  • Chart on Comparison by Route of Administration
  • Data Table on Comparison by Route of Administration
• 6.3 Oral - Market size and forecast 2023-2028
  • Chart on Oral - Market size and forecast 2023-2028 ($ million)
  • Data Table on Oral - Market size and forecast 2023-2028 ($ million)
  • Chart on Oral - Year-over-year growth 2023-2028 (%)
  • Data Table on Oral - Year-over-year growth 2023-2028 (%)
• 6.4 Parenteral - Market size and forecast 2023-2028
  • Chart on Parenteral - Market size and forecast 2023-2028 ($ million)
  • Data Table on Parenteral - Market size and forecast 2023-2028 ($ million)
  • Chart on Parenteral - Year-over-year growth 2023-2028 (%)
  • Data Table on Parenteral - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Route of Administration
  • Market opportunity by Route of Administration ($ million)
  • Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 7.3 Antacid - Market size and forecast 2023-2028
  • Chart on Antacid - Market size and forecast 2023-2028 ($ million)
  • Data Table on Antacid - Market size and forecast 2023-2028 ($ million)
  • Chart on Antacid - Year-over-year growth 2023-2028 (%)
  • Data Table on Antacid - Year-over-year growth 2023-2028 (%)
• 7.4 PPI - Market size and forecast 2023-2028
  • Chart on PPI - Market size and forecast 2023-2028 ($ million)
  • Data Table on PPI - Market size and forecast 2023-2028 ($ million)
  • Chart on PPI - Year-over-year growth 2023-2028 (%)
  • Data Table on PPI - Year-over-year growth 2023-2028 (%)
• 7.5 H2 receptor antagonist drugs - Market size and forecast 2023-2028
  • Chart on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
  • Data Table on H2 receptor antagonist drugs - Market size and forecast 2023-2028 ($ million)
  • Chart on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
  • Data Table on H2 receptor antagonist drugs - Year-over-year growth 2023-2028 (%)
• 7.6 Prokinetic drugs - Market size and forecast 2023-2028
  • Chart on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
  • Data Table on Prokinetic drugs - Market size and forecast 2023-2028 ($ million)
  • Chart on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
  • Data Table on Prokinetic drugs - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape2023-2028 (%)
  • Data Table on Market share By Geographical Landscape2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity by geography
  • Market opportunity By Geographical Landscape($ million)
  • Data Tables on Market opportunity By Geographical Landscape($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Market positioning of companies
  • Matrix on companies position and classification
• 12.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
• 12.4 Alkem Laboratories Ltd.
  • Alkem Laboratories Ltd. - Overview
  • Alkem Laboratories Ltd. - Business segments
  • Alkem Laboratories Ltd. - Key offerings
  • Alkem Laboratories Ltd. - Segment focus
• 12.5 Apotex Inc.
  • Apotex Inc. - Overview
  • Apotex Inc. - Product / Service
  • Apotex Inc. - Key news
  • Apotex Inc. - Key offerings
• 12.6 AstraZeneca Plc
  • AstraZeneca Plc - Overview
  • AstraZeneca Plc - Product / Service
  • AstraZeneca Plc - Key news
  • AstraZeneca Plc - Key offerings
• 12.7 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
• 12.8 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
• 12.9 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
• 12.10 Dr Reddys Laboratories Ltd.
  • Dr Reddys Laboratories Ltd. - Overview
  • Dr Reddys Laboratories Ltd. - Business segments
  • Dr Reddys Laboratories Ltd. - Key news
  • Dr Reddys Laboratories Ltd. - Key offerings
  • Dr Reddys Laboratories Ltd. - Segment focus
• 12.11 Eisai Co. Ltd.
  • Eisai Co. Ltd. - Overview
  • Eisai Co. Ltd. - Business segments
  • Eisai Co. Ltd. - Key offerings
  • Eisai Co. Ltd. - Segment focus
• 12.12 Fresenius SE and Co. KGaA
  • Fresenius SE and Co. KGaA - Overview
  • Fresenius SE and Co. KGaA - Business segments
  • Fresenius SE and Co. KGaA - Key news
  • Fresenius SE and Co. KGaA - Key offerings
  • Fresenius SE and Co. KGaA - Segment focus
• 12.13 GlaxoSmithKline Plc
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key news
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Segment focus
• 12.14 inovapharma.com
  • inovapharma.com - Overview
  • inovapharma.com - Product / Service
  • inovapharma.com - Key offerings
• 12.15 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 12.16 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Product / Service
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
• 12.17 Perrigo Co. Plc
  • Perrigo Co. Plc - Overview
  • Perrigo Co. Plc - Business segments
  • Perrigo Co. Plc - Key offerings
  • Perrigo Co. Plc - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations